{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:59:47Z","timestamp":1767135587179,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd006468.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000}}],"reference-count":78,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006468.pub5","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T15:06:23Z","timestamp":1413385583000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anticoagulation for people with cancer and central venous catheters"],"prefix":"10.1002","author":[{"given":"Elie A","family":"Akl","sequence":"first","affiliation":[{"name":"American University of Beirut; Department of Internal Medicine; Riad El Solh St Beirut Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie P","family":"Ramly","sequence":"additional","affiliation":[{"name":"American University of Beirut; Faculty of Medicine; Beirut Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara A","family":"Kahale","sequence":"additional","affiliation":[{"name":"American University of Beirut; Faculty of Medicine; Beirut Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor E D","family":"Yosuico","sequence":"additional","affiliation":[{"name":"Buffalo Medical Group; 85 High Street Buffalo New York USA 14203-1149"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Barba","sequence":"additional","affiliation":[{"name":"Regina Elena National Cancer Institute; Division of Medical Oncology B - Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sperati","sequence":"additional","affiliation":[{"name":"Regina Elena National Cancer Institute; Biostatistics-Scientific Direction; Via Elio Chianesi 53 Rome Italy 00144"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Cook","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Clinical Epidemiology and Biostatistics; 1200 Main Street West HSC-2C11 Hamilton ON Canada L8N 3Z5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"McMaster University; Departments of Clinical Epidemiology and Biostatistics and of Medicine; 1280 Main Street West Hamilton ON Canada L8N 4K1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0002|cit2","unstructured":"Bern MM Lokich JJ Wallach SR Huberman M Tangen O Very low-dose warfarin prevents thrombosis in central vein catheters ASCO Annual Meeting Proceedings 1986 254"},{"issue":"12","key":"10.1002\/14651858.CD006468.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/annonc\/mdp235","article-title":"Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies","volume":"20","author":"Cicco","year":"2009","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"De Cicco M Matovic M Pacenzia R Fantin D Caserta M Bortolussi R Short-term acenocumarine (A) or dalteparine (D) for the prevention of central venous catheter-related thrombosis (CVCrT) in cancer patients. A randomized controlled study based on serial venographies Journal of Clinical Oncology 2006 18","DOI":"10.1200\/jco.2006.24.18_suppl.8549"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1445-5994.2002.00171.x","article-title":"Minidose (1mg) warfarin as prophylaxis for central vein catheter thrombosis","volume":"32","author":"Heaton","year":"2002","journal-title":"Internal Medicine Journal"},{"issue":"2","key":"10.1002\/14651858.CD006468.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/annonc\/mdj059","article-title":"Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial","volume":"17","author":"Karthaus","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0007|cit7","first-page":"1474","article-title":"A phase III randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (dalteparin sodium, fragmin) in preventing catheter-related complications (CRCs) in cancer patients with central venous catheters (CVCs)","volume":"21","author":"Reichardt","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-013-2169-y","article-title":"Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study","volume":"72","author":"Lavau-Denes","year":"2013","journal-title":"Cancer Chemotherapy Pharmacology"},{"issue":"2-3","key":"10.1002\/14651858.CD006468.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thrombosis Research"},{"issue":"1","key":"10.1002\/14651858.CD006468.pub5-BIB0010|cit10","first-page":"67","article-title":"Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial","volume":"88","author":"Mismetti","year":"2003","journal-title":"Haematologica"},{"issue":"2","key":"10.1002\/14651858.CD006468.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thrombosis & Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD006468.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/j.1538-7836.2007.02660.x","article-title":"Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study","volume":"5","author":"Niers","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD006468.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/08035250600729092","article-title":"Low-dose warfarin for the prevention of central line-associated thrombosis in children with malignancies - a randomized, controlled study","volume":"95","author":"Ruud","year":"2006","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Agnelli G Verso M Bertoglio S Ageno W Bazzan M Parise P A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter Journal of Clinical Oncology 2004 734S","DOI":"10.1200\/jco.2004.22.14_suppl.8021"},{"issue":"18","key":"10.1002\/14651858.CD006468.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2005.06.084","article-title":"Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients","volume":"23","author":"Verso","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"16S","key":"10.1002\/14651858.CD006468.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1200\/jco.2005.23.16_suppl.lba8004","article-title":"WARP - a multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs)","volume":"23","author":"Young","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"9663","key":"10.1002\/14651858.CD006468.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(09)60205-1","article-title":"Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial","volume":"373","author":"Young","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD006468.pub5-BIB0018|cit18","first-page":"654","article-title":"Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-ontological disease - a randomized controlled trial","volume":"92","author":"Abdelkefi","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0019|cit19","first-page":"651","article-title":"Hickman catheter clots: a common occurrence despite daily heparin flushing","volume":"71","author":"Anderson","year":"1987","journal-title":"Cancer Treatment Reports"},{"issue":"1","key":"10.1002\/14651858.CD006468.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1378\/chest.95.1.71","article-title":"Thrombosis: the major Hickman catheter complication in patients with solid tumor","volume":"95","author":"Anderson","year":"1989","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD006468.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Barman B Ghosh R Mondal A Saha K Mukhopadhyay S Mukhopadhyay A Central venous catheters in bone marrow transplantation and leukemia patients Journal of Clinical Oncology 2005 8269","DOI":"10.1200\/jco.2005.23.16_suppl.8269"},{"issue":"3","key":"10.1002\/14651858.CD006468.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2141.1998.00732.x","article-title":"Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies","volume":"101","author":"Boraks","year":"1998","journal-title":"British Journal of Haematology"},{"issue":"11","key":"10.1002\/14651858.CD006468.pub5-BIB0024|cit24","first-page":"4195","article-title":"Prophylaxis of venous thrombosis (VT) associated with central venous catheter (CVC) with low molecular weight heparin (LMWH) in hematologic malignancies","volume":"102","author":"Conte","year":"2003","journal-title":"Blood"},{"issue":"18","key":"10.1002\/14651858.CD006468.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1200\/JCO.2005.10.192","article-title":"Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer","volume":"23","author":"Couban","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"8020","DOI":"10.1200\/jco.2004.22.14_suppl.8020","article-title":"Factor V Leiden mutation in patients with breast cancer and a central venous catheter: relationship with deep vein thrombosis","volume":"22","author":"Curigliano","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10.1002\/14651858.CD006468.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2004.07.019","article-title":"Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study","volume":"22","author":"Dillon","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD006468.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001622-200307000-00002","article-title":"Thromboembolic complications related to indwelling central venous catheters in children","volume":"15","author":"Freytes","year":"2003","journal-title":"Current Opinion in Oncology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0029|cit29","first-page":"15","article-title":"Warfarin (WP) dose and incidence of port-related thrombotic complications (CMPs) in cancer patients (pts)","volume":"15","author":"Gould","year":"1996","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD006468.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1600-0463.2012.02910.x","article-title":"Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin","volume":"120","author":"Handrup","year":"2012","journal-title":"APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.2000.18.6.1269","article-title":"Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin\/ciprofloxacin\/heparin flush solution: a randomized, multicenter, double-blind trial","volume":"18","author":"Henrickson","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0032|cit32","first-page":"1634","article-title":"Subcutaneous ports used for vascular access need only be flushed every eight weeks to maintain patency","volume":"20","author":"Hoffman","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD006468.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1592\/phco.26.9.1262","article-title":"Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices","volume":"26","author":"Horne","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD006468.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1538-7836.2005.01735.x","article-title":"Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups","volume":"4","author":"Huisman","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0035|cit35","first-page":"3151","article-title":"Dalteparin is effective as prophylaxis of central venous catheter related thrombosis in cancer patients","volume":"22","author":"Iniesta","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"26-27","key":"10.1002\/14651858.CD006468.pub5-BIB0036|cit36","first-page":"1984","article-title":"Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now","volume":"102","author":"Jansson","year":"2005","journal-title":"Lakartidningen"},{"issue":"16","key":"10.1002\/14651858.CD006468.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/archinte.163.16.1913","article-title":"Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review","volume":"163","author":"Klerk","year":"2003","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006468.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archinte.164.4.459-b","article-title":"Thrombosis prophylaxis in cancer patients with a central venous catheter - in reply","volume":"164","author":"Klerk","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006468.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2002-32656","article-title":"Thromboembolic prophylaxis with dalteparin-Na (Fragmin) in oncological patients following port implantations","volume":"23","author":"Lersch","year":"2002","journal-title":"Tumor Diagnostik und Therapie"},{"issue":"18","key":"10.1002\/14651858.CD006468.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2005.12.901","article-title":"Catheter-associated thrombosis: thromboprophylaxis or not?","volume":"23","author":"Levine","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"14S","key":"10.1002\/14651858.CD006468.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1200\/jco.2004.22.14_suppl.8102","article-title":"Retrospective analysis of central venous catheter-related thrombosis in 427 cancer patients prophylaxed with low-dose warfarin","volume":"22","author":"Magagnoli","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD006468.pub5-BIB0042|cit42","first-page":"3143","article-title":"Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients","volume":"25","author":"Magagnoli","year":"2005","journal-title":"Anticancer Research"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0043|cit43","unstructured":"Park K Oh SY Kim WS Jeong HS Lee JT Kong K Randomized phase III trial of very low dose warfarin to prevent catheter-associated thrombosis American Society of Clinical Oncology 1999 2330"},{"issue":"5","key":"10.1002\/14651858.CD006468.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2257.1999.00250.x","article-title":"Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease","volume":"21","author":"Ratcliffe","year":"1999","journal-title":"Clinical and Laboratory Haematology"},{"issue":"16S","key":"10.1002\/14651858.CD006468.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1200\/jco.2005.23.16_suppl.8155","article-title":"The influence of externalised Groshong catheters or subcutaneously implanted ports on normal daily activities of cancer patients","volume":"23","author":"Romano","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD006468.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0959-8049(01)00320-3","article-title":"Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin","volume":"37","author":"Solomon","year":"2001","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0047|cit47","first-page":"1584","article-title":"Prophylaxis with low molecular weight heparin reduces the risk for catheter-related venous thrombosis in cancer patients in centrally, but not in peripherally, inserted central venous catheters","volume":"20","author":"Tesselaar","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD006468.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/oxfordjournals.annonc.a058188","article-title":"Effective prevention of chemotherapy-induced phlebitis by low-dose heparin: a prospective randomised trial","volume":"3","author":"Th\u00fcrlimann","year":"1992","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006468.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2141.2003.04638.x","article-title":"Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound","volume":"123","author":"Rooden","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0050|cit50","unstructured":"A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Fragmin (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients With Central Venous Catheters Ongoing study April 2000"},{"issue":"2","key":"10.1002\/14651858.CD006468.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"e57132","DOI":"10.1371\/journal.pone.0057132","article-title":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"8","author":"Akl","year":"2013","journal-title":"PLoS One"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006468.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD006468.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-994916","article-title":"Thrombotic complications of central venous catheters in cancer patients","volume":"25","author":"Bona","year":"1999","journal-title":"Seminars in Thrombosis & Hemostasis"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1160\/TH07-07-0446","article-title":"Thromboprophylaxis in cancer patients with central venous catheters: a systematic review and meta-analysis","volume":"99","author":"Chaukiyal","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0056|cit56","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"9","key":"10.1002\/14651858.CD006468.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jclinepi.2013.03.014","article-title":"Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers.","volume":"66","author":"Ebrahim","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0060|cit60","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0061|cit61","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD006468.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0038-1646191","article-title":"Low molecular weight heparin","volume":"70","author":"Hirsh","year":"1993","journal-title":"Thrombosis & Haemostasis"},{"issue":"17","key":"10.1002\/14651858.CD006468.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD006468.pub5-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006468.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-994915","article-title":"The thrombophilic state induced by therapeutic agents in the cancer patient","volume":"25","author":"Lee","year":"1999","journal-title":"Seminars in Thrombosis & Hemostasis"},{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1365-2141.2003.04199.x","article-title":"Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study","volume":"120","author":"Lordick","year":"2003","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD006468.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1648912","article-title":"Pulmonary embolism in patients with upper extremity DVT associated to venous central lines - a prospective study","volume":"72","author":"Monreal","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"issue":"17","key":"10.1002\/14651858.CD006468.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.294.17.2203","article-title":"Randomized trials stopped early for benefit: a systematic review","volume":"294","author":"Montori","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD006468.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD006468.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1160\/TH09-12-0812","article-title":"Expression of concern: non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors","volume":"104","author":"Ruinemans-Koerts","year":"2010","journal-title":"Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD006468.pub5-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009160.pub2","article-title":"Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters","author":"Schoot","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006468.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006468.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(24)01481-9","article-title":"The complex effects of heparins on cancer progression and metastasis in experimental studies","volume":"53","author":"Smorenburg","year":"2001","journal-title":"Pharmacological Review"},{"issue":"25","key":"10.1002\/14651858.CD006468.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006468.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajh.10263","article-title":"Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment","volume":"72","author":"Sutherland","year":"2003","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD006468.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0305-7372(02)00040-3","article-title":"Can low-molecular-weight heparins improve outcomes in patients with cancer?","volume":"28","author":"Thodiyil","year":"2002","journal-title":"Cancer Treatment Reviews"},{"issue":"11","key":"10.1002\/14651858.CD006468.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"issue":"19","key":"10.1002\/14651858.CD006468.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2003.08.008","article-title":"Venous thromboembolism associated with long-term use of central venous catheters in cancer patients","volume":"21","author":"Verso","year":"2003","journal-title":"Journal of Clinical Oncology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006468.pub6","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006468.pub5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:45:23Z","timestamp":1746405923000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006468.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":78,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006468.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]}}}